In the phase II DESTINY-Lung01 trial, 4 patients in the HER2 -mutant cohort presented with grade 3 drug-related ILD and two patients with a grade 5 [4]
Orforgliprons approval highlights both the growing role of GLP-1 therapies in weight loss and the potential for faster regulatory pathways, bringing new treatments to patients sooner
It may also be used post-surgically: for instance, after plastic surgery or a burn injury, GHK-Cu injections or topical applications can help reduce scarring
It can boost insulin-like growth factor 1 (IGF-1) production in the body via stimulation of the pituitary gland
Click on the JSmol tab to take a closer look at how GLP-1 (PDB 6X18), semaglutide (PDB 7KI0), tirzepatide (PDB 7FIM), and orforglipron (PDB 6XOX) are able to stabilize the active form of the GLP-1 receptor, and compare these structures to that of the inactive GLP-1 receptor (PDB 6LN2)
SAM and SAH help make important molecules like creatine, detoxify the body, produce energy (ATP), and support neurotransmitters